RecruitingNCT06532734

Barrett's Esophagitis in Anorexia Nervosa Binge/Purge Subtype

Presence of Barrett's Esophagitis in a Cohort of People With Eating Disorders Who Engage in Purging Behaviors: A Pilot Study


Sponsor

Denver Health and Hospital Authority

Enrollment

25 participants

Start Date

Nov 12, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

To better define the presence of Barrett's esophagus (BE) via non-endoscopic testing in an eating disorder cohort with purging (vomiting/rumination) behaviors


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study investigates whether people with anorexia nervosa who regularly purge (vomit after eating) are at higher risk of developing Barrett's esophagus — a serious condition where stomach acid repeatedly damages the lining of the esophagus (food pipe), which can sometimes lead to cancer. Researchers want to understand how many years of purging it takes for this damage to occur, and whether routine screening should be offered to this group of patients. **You may be eligible if...** - You have an eating disorder that involves purging (such as anorexia nervosa binge/purge subtype or bulimia) - You are 18 to 65 years old - You have been purging for 5 or more years - You currently purge or ruminate at least once daily - You are admitted to the ACUTE Center for Eating Disorders and Severe Malnutrition **You may NOT be eligible if...** - Your eating disorder does not involve purging - You are under 18 or over 65 - You already meet standard guidelines for Barrett's esophagus screening (chronic acid reflux plus other risk factors) - You are receiving mandated treatment at the time of enrollment - You are unable to give informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEsoGuard

device used to collect esophageal cell samples to test for the presence of abnormal cells which may indicate a dx of Barrett's esophagitis.


Locations(3)

ACUTE Center for Eating Disorders and Severe Malnutrition

Denver, Colorado, United States

Denver Health and Hospital Authority

Denver, Colorado, United States

Denver Health and Hospital Authority

Denver, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06532734


Related Trials